Literature DB >> 8720313

Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs.

T Efferth1, G Rücker, M Falkenberg, D Manns, A Olbrich, U Fabry, R Osieka.   

Abstract

Four investigational drugs, p-benzoquinone, primine, miconidine acetate, and artesunate (dihydroqinghaosusuccinate), with growth inhibitory activity against flagellatae (e.g. trypanosoma, leptomonas, plasmodium) were investigated for their capability to induce programmed cell death (apoptosis) in human KG-1a leukemic cells. The results were compared with those of three well established cytostatic agents (cisplatin, daunorubicin, cytosine-arabinoside) and ionizing radiation. The antitumor activity of the drugs was validated by a cellular growth inhibition assay. The depletion of glutathione by these four investigational drugs favours the hypothesis that formation of free radicals and subsequent DNA strand breaks may be critical mechanisms of action and that the glutathione redox cycle is involved in detoxification of these reactive molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720313

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  25 in total

1.  Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cells.

Authors:  Zeljko Zizak; Zorica Juranić; Dejan Opsenica; Bogdan A Solaja
Journal:  Invest New Drugs       Date:  2008-11-15       Impact factor: 3.850

2.  MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells.

Authors:  Mariana Franzoni Maioral; Natália Marceli Stefanes; Álisson Bigolin; Gabriele Andressa Zatelli; Ana Cláudia Philippus; Miriam de Barcellos Falkenberg; Maria Cláudia Santos-Silva
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

3.  A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.

Authors:  J L Moran; D Siegel; D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 4.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

5.  Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells.

Authors:  V Badireenath Konkimalla; Martina Blunder; Bernhard Korn; Shahid A Soomro; Herwig Jansen; Wonsuk Chang; Gary H Posner; Rudolf Bauer; Thomas Efferth
Journal:  Nitric Oxide       Date:  2008-04-22       Impact factor: 4.427

6.  NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death.

Authors:  Chuan Bian Lim; Pan You Fu; Nung Ky; Hong Shuang Zhu; XiaoLing Feng; Jinming Li; Kandhadayar Gopalan Srinivasan; Mohamed Sabry Hamza; Yan Zhao
Journal:  BMC Complement Altern Med       Date:  2012-07-11       Impact factor: 3.659

7.  Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Authors:  Beatrice Bachmeier; Iduna Fichtner; Peter H Killian; Emanuel Kronski; Ulrich Pfeffer; Thomas Efferth
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

8.  (1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxy-per-hydropyrano[4,3-j][1,2]benzodiox-epine.

Authors:  Lijun Xie; Xin Zhai; Jian Zuo; Yanfang Zhao; Ping Gong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-26

9.  Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo.

Authors:  Ji-Hui Du; Hou-De Zhang; Zhen-Jian Ma; Kun-Mei Ji
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-19       Impact factor: 3.333

Review 10.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.